This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Endocrine Disease, Fertility Decreased Male or DNA Damage
and you are
over 16
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

Accumulation of iron in patients with beta thalassemia major causes free radical formation which leads to damage of biological membranes. Sperm DNA damage may result from these generated antioxidants. We aimed at investigating the current DNA damage in the sperms of adult patients with beta thalassemia major and the effect generated by giving antioxidant treatment for 6 months.

Provided treatments

  • Drug: L-Carnitine and N-acetyl cysteine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03014882. The sponsor of the trial is Ain Shams University and it is looking for 30 volunteers for the current phase.
Official trial title:
Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?